Tag: #clinicaltrials

Lilly’s daily GLP-1 pill beats Novo’s oral semaglutide in diabetes trial, but side effects drive more dropouts

A Phase 3 head-to-head study finds Lilly’s orforglipron lowered A1c and weight more than Rybelsus, with higher quit rates.

#diabetes, #glp1, #weightloss, #pharma, #clinicaltrials

CRISPR-Edited ‘Off-the-Shelf’ CAR-T Cells Show Early Promise Against Recurrent Glioblastoma in Small China Trial

In a five-patient phase 1 study, intrathecal CRISPR-edited donor CAR-T cells appeared safe and shrank recurrent high-grade gliomas.

#glioblastoma, #cart, #crispr, #immunotherapy, #clinicaltrials